Cargando…
Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
The main features of a giant cell tumor of bone (GCTB) are frequent recurrence and aggressive osteolysis, which leads to a poor prognosis in patients. Although the treatment methods for a GCTB, such as scraping and resection, effectively inhibit the disease, the tendency toward malignant transformat...
Autores principales: | Fan, Mengke, Zhang, Guochuan, Xie, Mingfang, Liu, Xinbo, Zhang, Qi, Wang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600077/ https://www.ncbi.nlm.nih.gov/pubmed/36290882 http://dx.doi.org/10.3390/curroncol29100605 |
Ejemplares similares
-
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021) -
Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023) -
Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis
por: Jiang, Kui-Ying, et al.
Publicado: (2023) -
Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022) -
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)